AI news
Isomorphic Labs announces a $5 billion Series C for AI drug design
Isomorphic Labs announced $5 billion in Series C funding co-led by Greenoaks and Sequoia Capital, with additional investors including Alphabet. The financing supports its AI drug-design engine and therapeutic pipeline; no approved medicine, revenue or valuation is established by the announcement.
Primary source · Isomorphic Labs · November 17, 2026
Opens Isomorphic Labs in a new tab. Read it there before you rely on the summary above.
Read the original
Free, email only
Unlock the full brief free.
- What to check before you trust this story, written down
- Each verified source, with why it matters and who published it
- A note whenever a source has been withdrawn
- Thirty days of stories to browse, not seven
Continuing subscribes the email on that account to Work Worth Doing, my newsletter, the same as the form below, and unlocks every free tool in this browser. We only receive your email address. Unsubscribe in one click.
